Scilex Holding (SCLX) Enterprise Value (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Enterprise Value of -$149.9 million for Q1 2026, down 2484.9% year-over-year from $6.3 million in Q1 2025, and down 891.17% on a QoQ basis from -$15.1 million in Q4 2025.

Scilex Holding (SCLX) Enterprise Value (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Enterprise Value for 7 consecutive years, with -$149.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Enterprise Value fell 2484.9% year-over-year to -$149.9 million; the TTM figure through Mar 2026 stood at -$149.9 million (down 2484.9% YoY), while the FY2025 annual figure was -$15.1 million, down 362.29% from the prior year.
  • Enterprise Value came in at -$149.9 million for Q1 2026 at Scilex Holding, down from -$15.1 million in the prior quarter.
  • The five-year high for Enterprise Value was -$69922.0 in Q3 2022, with the low at -$149.9 million in Q1 2026.
  • Average Enterprise Value over 5 years is -$30.6 million, with a median of -$4.1 million recorded in 2025.
  • The largest YoY upside for Enterprise Value was 98.48% in 2022 against a maximum downside of 55034.43% in 2022.
  • Year by year, Enterprise Value stood at -$2.2 million in 2022, then plunged by 79.53% to -$3.9 million in 2023, then grew by 16.55% to -$3.3 million in 2024, then sank by 362.29% to -$15.1 million in 2025, then slumped by 891.17% to -$149.9 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$149.9 million, -$15.1 million, and -$3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -5.28 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -22.05 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -9.35 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -7.89 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -5.65 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -12.04 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -7.73 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -12.77 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - 315.00 Mn
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn -149.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -149.92 Mn
Dec 31, 2025 -15.13 Mn
Sep 30, 2025 -3.68 Mn
Jun 30, 2025 -4.10 Mn
Mar 31, 2025 -5.80 Mn
Dec 31, 2024 -3.27 Mn
Sep 30, 2024 -77,000.00
Jun 30, 2024 -6.89 Mn
Mar 31, 2024 -1.82 Mn
Dec 31, 2023 -3.92 Mn
Sep 30, 2023 -2.00 Mn
Jun 30, 2023 -34.12 Mn
Mar 31, 2023 -5.10 Mn
Dec 31, 2022 -2.18 Mn
Sep 30, 2022 -69,922.00
Jun 30, 2022 -142.04 Mn
Mar 31, 2022 -140.58 Mn
Dec 31, 2021 -143.75 Mn
Sep 30, 2021 -115,642.00
Jun 30, 2021 -257,621.00